Alberta Health Services. (2012, November). Targeted therapy for Locally Advanced Unresectable or Metastatic Medullary Thyroid Carcinoma: Clinical Practice Guideline ENDO-002 Version 1. Retrieved from: http://www.albertahealthservices.ca/hp/if-hp-cancer-guide-endo002-targeted-therapy-mtc.pdf.
American Cancer Society. (2014, February 24). Thyroid Cancer. Retrieved from: http://www.cancer.org/cancer/thyroidcancer/detailedguide/index.
American Society of Clinical Oncology. (2015, May). Thyroid Cancer. Retrieved from: http://www.cancer.net/cancer-types/thyroid-cancer/view-all.
Cancer Care Ontario. (2015, January). Drug Monograph: Sorafenib. Retrieved from: https://www.cancercare.on.ca/cms/One.aspx?portalId=1377&pageId=10760.
Cancer Care Ontario. (2014, February). Drug Monograph: Vandetanib. Retrieved from: https://www.cancercare.on.ca/cms/One.aspx?portalId=1377&pageId=10760.
Davidge-Pitts CJ, Thompson GB. Thyroid tumors. DeVita VT Jr, Lawrence TS, Rosenberg SA. (2015). Cancer: Principles and Practice of Oncology. (10th Edition). Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. 82:1175-1188.
Davidson BJ, Newkirk KA, Burman KD. Cancer of the thyroid and the parathyroid: general principles and management. Harrison LB, Sessions RB, Kies MS (eds.). (2014). Head and Neck Cancer: A Multidisciplinary Approach. (4th Edition). Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins. 28A:779-824.
Lentsch EJ. (2015, February 27). Medscape Reference: Thyroid Cancer Treatment Protocols. Retrieved from: http://emedicine.medscape.com/article/2007769-overview.
National Cancer Institute. (2015, May 13). Thyroid Cancer Treatment for Health Professionals (PDQ®). Retrieved from: http://www.cancer.gov/types/thyroid/hp/thyroid-treatment-pdq.
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Thyroid Carcinoma (Version 2.2015). Retrieved from: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp.×